(2R,3R,4S,5R)-2-(3H-[1,2,3]Triazolo[4,5-d]pyrimidin-3-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol

Catalog No. :
ACJSGA087
CAS No. :
38874-46-3
Molecular Formula :
C9H11N5O4
Molecular Weight :
253.22

IUPAC Name:(2R,3R,4S,5R)-2-(3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol

(2R,3R,4S,5R)-2-(3H-[1,2,3]Triazolo[4,5-d]pyrimidin-3-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg95%$239.00Login to see priceInquiryInquiry
5mg95%$526.00Login to see priceInquiryInquiry
10mg95%$871.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2R,3R,4S,5R)-2-(3H-[1,2,3]Triazolo[4,5-d]pyrimidin-3-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
IUPAC Name(2R,3R,4S,5R)-2-(3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
Molecular FormulaC9H11N5O4
Molecular Weight253.22
SMILESO[C@@H]1[C@@H](CO)O[C@@H](N2N=NC3=CN=CN=C32)[C@@H]1O
InChI KeyXOUCEKYAMMLQRC-JXOAFFINSA-N
Synonym8-Azanebularine;3H-1,2,3-Triazolo[4,5-d]pyrimidine, 3-β-D-ribofuranosyl-;(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(triazolo[4,5-d]pyrimidin-3-yl)tetrahydrofuran-3,4-diol
CAS No.38874-46-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364

Synthetic Route by SureRoute

1. ACJSGA087 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJSGA087 route product structure diagram
    ACJSGA08738874-46-3
Inquiry

2. ACJSGA087 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJSGA087 route product structure diagram
    ACJSGA08738874-46-3
Inquiry

Comments (0)